SOCIETY SUPPORT FOR CARDIAC PET -
ASNC POSITIONING STATEMENT
SOCIETY SUPPORT FOR CARDIAC PET - ASNC POSITIONING STATEMENT
The American Society of Nuclear Cardiology recommends that PET MPI, if available, be the preferred modality for all patients who meet criteria for MPI. There are no clinical scenarios or patient subgroups in which the use of PET MPI should be excluded, given its diagnostic accuracy, risk stratification, and unique quantitative capabilities.
REFERENCE:
Bateman TM, et al. Clinical Indications for PET Myocardial Perfusion Imaging and Myocardial Blood Flow Quantification: ASNC Position Statement. Journal of Nuclear Cardiology, 2025.
Share a few details to start a conversation about how Cardiac PET could fit your hospital.
CDL's on-demand Rubidium-82 delivery model helps hospitals launch Cardiac PET without permanent generator ownership or making a long-term infrastructure decision on day one.
Begin scanning, validate demand and align stakeholders while building a clear path forward.
CDL's on-demand Rubidium-82 delivery model helps hospitals launch Cardiac PET without permanent generator ownership or making a long-term infrastructure decision on day one.
Begin scanning, validate demand and align stakeholders while building a clear path forward.

NO CONSTRUCTION. NO LONG-TERM COMMITMENT.
NO UNNECESSARY DISRUPTION.
NO CONSTRUCTION. NO LONG-TERM COMMITMENT. NO UNNECESSARY DISRUPTION.


Personalized recommendations based on your program
Guidance on operational and staffing considerations
A scalable roadmap from mobile to permanent solutions
A CONNECTED PATHWAY, NOT A SINGLE SOLUTION
Cardiac PET 360 is CDL’s comprehensive approach to supporting Cardiac PET programs. It brings together scalable pathways, delivery models, and program support designed to evolve with your practice whether you are just getting started or planning for long-term growth.
